The Helix-II epitope: a cautionary tale from a cartilage biomarker based on an invalid collagen sequence
- 30 April 2009
- journal article
- research article
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 17 (4), 423-426
- https://doi.org/10.1016/j.joca.2009.02.005
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The response to oestrogen deprivation of the cartilage collagen degradation marker, CTX-II, is unique compared with other markers of collagen turnoverArthritis Research & Therapy, 2009
- PIIANP and HELIXII diurnal variationOsteoarthritis and Cartilage, 2008
- The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradationOsteoarthritis and Cartilage, 2008
- Extracellular Matrix Turnover and Inflammatory Markers Independently Predict Functional Status and Outcome in Chronic Heart FailureJournal of Cardiac Failure, 2008
- Biochemical Markers as Surrogate End Points of Joint DiseasePublished by Springer Nature ,2008
- New biochemical markers of cartilage turnover in osteoarthritis: Recent developments and remaining challengesBoneKEy Reports, 2007
- Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritisAnnals Of The Rheumatic Diseases, 2006
- Urinary type II collagen helical peptide (HELIX‐II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritisArthritis & Rheumatism, 2005
- Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damageAnnals Of The Rheumatic Diseases, 2001
- Nucleotide sequence of the full length cDNA encoding for human type II procollagenNucleic Acids Research, 1989